Diarrhea represents another commonly observed gastrointestinal side effect that may affect patients using this medication
Glucagon-like peptide-1 (GLP-1) agonists, also called GLP-1 receptor agonists or incretin mimetics, are a class of prescription medications used primarily to manage type 2 diabetes mellitus and, in some formulations, obesity
Avoiding these can save you from unnecessary side effects, wasted medication, and frustrating stalls in progress
It is typically marketed as a cosmetic product with limited clinical evidence
The study focused on muscle soreness, strength loss, and inflammation
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion